1. Fluorinated pyrimidines;Grem,1990
2. Raltitrexed— a review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer;Gunasekara;Drugs,1998
3. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331;Jackman;Clin. Cancer Res.,1997
4. Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks;Rees;Ann. Oncol.,1998
5. In vitro and in vivo pharmacology of the non-polyglutamated quinazoline antifolate thymidylate synthase (TS) inhibitor, ZD9331;Aherne;Ann Oncol,1996